It is with great pleasure that I would like to update our readers on last year’s changes and achievements.

I am happy to present our new Editorial Office team: Steffi Hentzelt – Publication Manager, Shelly Shochat – Editorial Office Specialist, and Denise Frey – Production Editor.

We welcome the new Editorial Board members who joined us last year. All are leading figures in their field: Dr. Arina ten Cate-Hoek from Maastricht University Medical Center, Netherlands; Dr. Noel Chan from McMaster University, Canada; Dr. Alison Moskowitz from Memorial Sloan Kettering Cancer Center, USA; Dr. Nicholas Short from MD Anderson Cancer Center, USA, and Dr. Deborah Rund from the Hebrew University, Israel.

We hope to continue and push our journal forward in view of its vision and mission, namely, publishing clinical as well as innovative translational research, applying high standards of clinical and scientific reporting, leadership in the field of clinical hematology publications, accessibility to our authors and readers, shortening the time lag from manuscript submission to decision-making, recruitment of peer reviewers, raising the impact factor, and increasing the number of readers and manuscript submissions.

In line with our policy of keeping the high standards of our journal and in view of the rising number of manuscripts submitted, the journal’s rejection rate is around 70%.

I am happy to say that the impact factor has been steadily rising with a current impact factor of 1.313.

We are pleased that the new sections launched in 2018 – “Patient Reported Outcomes” and “Interdisciplinary Perspectives in Hematology” – were “active” in 2019 and expect them to be even more so in 2020.

A special issue entitled “Iron Deficiency Anemia – Management in Different Clinical Settings” edited by Dr. Anat Gafter-Gvili and Dr. Michael Auerbach was published in May 2019, comprehensively covering the interdisciplinary aspects of iron deficiency in various disorders.

In line with the previous initiative, the authors of the most cited article as well as the most contributing Editorial Board reviewers were awarded for their contribution and efforts.

Finally, a new and more modern peer review system (ManuscriptManager) was introduced and activated. We hope that this will improve the review process.

We are still facing several challenges including the ongoing need to recruit qualified reviewers, efforts to increase the publication speed, and endeavor to raise the impact factor. With the leadership of our Editorial Board and Editorial Office team, we hope to achieve these missions in the future as well.

On behalf of the Editorial Board, I would like to thank our reviewers and contributors for their efforts and to encourage our readers to keep on with submission of the fruits of their professional work to Acta Haematologica.

© 2020 S. Karger AG, Basel
2020
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.